NO20026005L - Indolderivater nyttige for behandlingen av CNS-forstyrrelser - Google Patents

Indolderivater nyttige for behandlingen av CNS-forstyrrelser

Info

Publication number
NO20026005L
NO20026005L NO20026005A NO20026005A NO20026005L NO 20026005 L NO20026005 L NO 20026005L NO 20026005 A NO20026005 A NO 20026005A NO 20026005 A NO20026005 A NO 20026005A NO 20026005 L NO20026005 L NO 20026005L
Authority
NO
Norway
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
useful
Prior art date
Application number
NO20026005A
Other languages
English (en)
Other versions
NO323236B1 (no
NO20026005D0 (no
Inventor
Benny Bang-Andersen
Jakob Felding
Jan Kehler
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20026005L publication Critical patent/NO20026005L/no
Publication of NO20026005D0 publication Critical patent/NO20026005D0/no
Publication of NO323236B1 publication Critical patent/NO323236B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20026005A 2000-06-14 2002-12-13 Indolderivater, deres anvendelse og farmasoytiske sammensetninger omfattende disse NO323236B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000919 2000-06-14
US21244500P 2000-06-16 2000-06-16
PCT/DK2001/000406 WO2001096328A1 (en) 2000-06-14 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (3)

Publication Number Publication Date
NO20026005L true NO20026005L (no) 2002-12-13
NO20026005D0 NO20026005D0 (no) 2002-12-13
NO323236B1 NO323236B1 (no) 2007-02-05

Family

ID=26068835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026005A NO323236B1 (no) 2000-06-14 2002-12-13 Indolderivater, deres anvendelse og farmasoytiske sammensetninger omfattende disse

Country Status (20)

Country Link
US (2) US6890916B2 (no)
EP (1) EP1294710B1 (no)
JP (1) JP2004503550A (no)
KR (1) KR20030007967A (no)
AR (1) AR028685A1 (no)
AT (2) ATE297391T1 (no)
AU (2) AU2001273881B8 (no)
BG (1) BG107449A (no)
CA (1) CA2411412C (no)
CZ (1) CZ200335A3 (no)
DE (2) DE60130691T2 (no)
DK (1) DK1468996T3 (no)
ES (2) ES2243508T3 (no)
HR (1) HRP20021008A2 (no)
HU (1) HUP0301735A2 (no)
NO (1) NO323236B1 (no)
NZ (1) NZ523076A (no)
PT (2) PT1294710E (no)
SG (1) SG148840A1 (no)
WO (1) WO2001096328A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
EP1468996B1 (en) * 2000-06-14 2007-09-26 H. Lundbeck A/S Indole derivatives for the treatment of CNS disorders
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2003236207A1 (en) * 2002-05-31 2003-12-19 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
WO2004020437A1 (en) * 2002-08-29 2004-03-11 H. Lundbeck A/S S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
GB0708186D0 (en) * 2007-04-27 2007-06-06 Merck Sharp & Dohme Therapeutic compounds
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
AU8743098A (en) * 1997-08-22 1999-03-16 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
GB9718833D0 (en) * 1997-09-04 1997-11-12 Merck Sharp & Dohme Therapeutic agents
GB9810886D0 (en) * 1998-05-13 1998-07-22 Lilly Industries Ltd Pharmaceutical compounds
GB9825413D0 (en) * 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
AU4552200A (en) * 1999-05-12 2000-12-05 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
US6642228B1 (en) * 1999-06-24 2003-11-04 Toray Industries, Inc. α1b-adrenergic receptor antagonists
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines

Also Published As

Publication number Publication date
DE60130691D1 (de) 2007-11-08
AU7388101A (en) 2001-12-24
DE60111379D1 (de) 2005-07-14
JP2004503550A (ja) 2004-02-05
HRP20021008A2 (en) 2005-02-28
ATE374197T1 (de) 2007-10-15
PT1294710E (pt) 2005-10-31
DE60111379T2 (de) 2006-03-16
AR028685A1 (es) 2003-05-21
CA2411412C (en) 2008-09-02
AU2001273881B2 (en) 2005-12-22
NO323236B1 (no) 2007-02-05
BG107449A (bg) 2003-09-30
ATE297391T1 (de) 2005-06-15
HUP0301735A2 (hu) 2003-08-28
CZ200335A3 (cs) 2003-04-16
EP1294710B1 (en) 2005-06-08
DE60130691T2 (de) 2008-07-17
SG148840A1 (en) 2009-01-29
US6890916B2 (en) 2005-05-10
US20050176729A1 (en) 2005-08-11
US7276508B2 (en) 2007-10-02
US20030191133A1 (en) 2003-10-09
EP1294710A1 (en) 2003-03-26
PT1468996E (pt) 2007-11-28
ES2290587T3 (es) 2008-02-16
WO2001096328A1 (en) 2001-12-20
NO20026005D0 (no) 2002-12-13
ES2243508T3 (es) 2005-12-01
NZ523076A (en) 2004-09-24
DK1468996T3 (da) 2008-01-07
CA2411412A1 (en) 2001-12-20
AU2001273881B8 (en) 2006-02-09
KR20030007967A (ko) 2003-01-23

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20014047L (no) Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20026005L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
HRP20030052A2 (en) 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20026029D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20026028D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO993948D0 (no) Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser
HK1059086A1 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
NO20011189L (no) Innretning for behandling av suspensjoner